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doi:10.1016/j.ejvs.2009.06.005Abstract Objectives: To evaluate the results and complications of combined simultaneous
arterial re-vascularisation and free flap transfer in patients with critical limb ischaemia and
large soft-tissue defects that would otherwise have required major amputation.
Design: Retrospective analysis of all combined procedures performed between 1993 and 2007
with regard to complications and outcome.
Materials and methods: Seventy-eight procedures were performed in 76 patients with a mean
age of 60 years (range: 18e80 years). The majority had diabetes (70.5%). Follow-up was
obtained from hospital charts and telephone contacts with patients or GPs.
Results: The limb-salvage rate was 93% after 1 year, 80% after 3 years and 71% after 5 years.
Perioperative complications occurred in 50% of the patients; six out of 78 (7.7%) arterial recon-
structions and 13 out of 78 (16.7%) flaps had to be revised during the early postoperative
period. However, most flaps could be saved by a secondary procedure resulting in an early
failure (amputation) rate of 6%.
In-hospital mortality was 3.8%. End-stage renal disease was the only factor predicting limb
loss. In total, 65% of the patients survived and were able to walk on their reconstructed limb
at 1-year follow-up. Combined survival and limb-salvage rates were 85%, 66% and 51% after 1,
3 and 5 years.
Conclusions: Combined arterial re-vascularisation and free flap transfer can be performed safely
with acceptable morbidity andmortality and should be considered for every mobile patient with
large soft-tissue deficit (>10 cm2) without end-stage renal disease prior to major amputation.
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The increasing prevalence of diabetes and continuing
tobacco consumption still lead to a rise in the number of
patients with critical limb ischaemia and large soft-tissue
defects. Despite the increasing possibilities of distal
(endovascular) re-vascularisation and new wound-healing
techniques, wound healing and limb salvage can often not be
obtained when bones and/or tendons are exposed (TASC II).1
Major amputation, although sometimes unavoidable,
seldom leads to independent ambulation, is more expensive
than a successful re-vascularisation and negatively influ-
ences life expectancy.2 Combined lower limb re-vascular-
isation and free-tissue transfer to cover a large and deep
defect immediately provides adequate blood supply and
coverage of the wound with living tissue, leading to expe-
dient healing and full-length limb salvage.
Despite this technique being first described more than 20
years ago, it has not obtained widespread acceptance,
probably due to the presumed technical difficulties of the
procedure and the fear for morbidities or complications.
Therefore, we retrospectively evaluated our 15 years of
experience with special interest for the results with regard
to limb salvage, ambulation and the risks and complications
of the procedure.
Material and Methods
Patient selection
All the records of simultaneous combined re-vascularisation
and free-tissue transfer procedures (76 consecutive
patients with a total of 78 combined procedures) performed
between 1993 and 2007 were reviewed. This combined
procedure was the last attempt to avoid a major below- or
above-knee amputation, consequently patients excluded
for co-morbidities or unreconstructable ischaemia were
generally amputated. All patients had a large soft-tissue
deficit (exposed bone and/or tendon) (Rutherford grade 6)
and most were referred to our centre as lost case for limb
salvage. Only patients capable of regaining functional
ambulatory status were considered for operation. The
follow-up lasted till April 2007, till major amputation or
death.
Procedure
All patients had a preoperative angiography to determine
the extent of the arterial disease and to choose the
appropriate inflow and outflow vessel for the bypass
graft.
Whenever possible, we preferred a simultaneous inter-
vention to a staged procedure. Advantages of a simulta-
neous re-vascularisation and tissue transfer are that it is
easier to connect the free flap to the arterial bypass and
dissect the concomitant veins when no scar tissue is formed
yet, it shortens the operation time (the flap was prepared
by the plastic surgeons while vascular surgeons performed
the bypass graft) and the outflow of the arterial re-vascu-
larisation is enhanced by the free muscle flap transfer.
When not too extensive, we even prefer to combine thedebridement with the actual procedure to avoid further
dissection of the debrided tissue.
The ipsilateral greater saphenous vein was preferred for
distal re-vascularisations in an in-situ or in a non-reversed
non-in-situ fashion; if unavailable, a reversed contralat-
eral saphenous vein was used. When no ipsi- or contralat-
eral saphenous vein was available, a cryopreserved
homologous saphenous vein was favoured because of its
length and resistance to infection (most patients had
osteomyelitis at the defect). Heparin (100 IU kg1) was
administered 2 min before anastomosis of the bypass graft.
In 64% of the patients, a minor debridement or amputation
was needed for osteomyelitis or gangrene before flap
insertion.
Typically, a side-to-side anastomosis was performed on
the distal pedal vessel leaving one end of the saphenous
vein for an end-to-end anastomosis with the flap artery. In
other cases, the re-vascularised tibial artery closest to
the defect was used as inflow source for the free flap. The
nearest concomitant tibial vein served as an outflow for
the flap through an end-to-end anastomosis. If no deep vein
was accessible, we anastomosed to a neighbouring super-
ficial vein (six patients) or a mobilised lesser saphenous vein
(six patients). At first we preferred the rectus abdominis
muscle flap as a donor but due to donor-site wound-healing
complications, gastroparesis and the fact that the inferior
epigastric artery was frequently affected by atheroscle-
rosis, we now favour the anterolateral thigh flap (ALT).
According to our excellent results in reconstructive breast
surgery, we recently switched to the use of perforator
flaps, leaving the muscle in place and just transferring fat
and skin tissue with its pedicle; This results in less post-
operative pain and fewer wound-healing problems. The
muscular flaps were fixed and covered with split-thickness
skin grafts (Figs. 1e3).
Postoperative meticulous monitoring of the arterial graft
and free muscle flap was achieved by hourly Doppler
examination and temperature control. All patients were
treated on an air-fluidised bed to prevent decubitus ulcers
or pressure on the flap. As soon as the wound healed,
a slightly compressive elastic stocking was applied for
about 6 months to remodel the transferred muscle.
Ambulation started in the third postoperative week. The
median hospital stay was 48.3 days (range: 14e113 days).
Some hospital stays were extended for social back-up
problems. Patients were followed with serial duplex scan-
ning of the arterial reconstruction and inspection of the
free flap.
At present standard postoperative medication consists
of daily low-dose aspirin and 72 h intravenous heparin fol-
lowed by low-molecular-weight heparin (LMWH) in
a prophylactic dose till ambulation, combined with clopi-
dogrel or coumarins according to their co-morbidity. The
patients were followed with serial duplex scanning of the
arterial and flap reconstruction at 1 month, 3, 6, 12 months
and then annually. Long-term follow-up was assessed
through postoperative visits or telephone calls to treating
physicians. Successful ambulatory function was defined as
the ability of the patient to walk alone or with a cane or
walker. Patients requiring a wheelchair for mobility or using
their leg only for pivot functions were considered as
non-ambulatory.
Figure 1 Diabetic foot with major tissue defect: before,1 at the end of the procedure before covering with split-thickness graft,2
2 days3 and 1 year after a combined free muscle transfer and revascularization procedure,4 angiographic result.5
Figure 2 Treatment of a large ischemic lesion of the forefoot with a femorotibial bypass and rectus abdominis muscle flap
transfer in a 70 y old diabetes patient: preoperative view with exposed tendons and bones after forefoot amputation,1 posterior
tibial artery and vein exposure,2 rectus abdominis muscle flap with pedicle,3 vascularised muscle flap fixed on ischemic lesion
before and after covering with a split-thickness graft,4 peroperative angiographic result after free flap transfer,5 final result 1 year
postoperatively.6
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Figure 3 Principle of free vascularised flap for covering of
tissue deficit of the foot.
Table 1 Defect location
Location n %
Dorsum or ankle 12 15
Pretibial 9 12
Plantar or heel 23 29
Post transmetatarsal amputation 34 44
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Amputation free survival and patient survival were defined
as primary end-points. All pre- and postoperative data were
obtained from patient files at our department and from the
referring physicians. This retrospective study with
prospective follow-up complied with the Declaration of
Helsinki and was approved by the ethics committee of the
Ghent University Hospital. Limb salvage and combined limb
salvage patient survival analyses were obtained through the
KaplaneMeier survival analysis.
Co-variate interactions with treatment (diabetes, clin-
ical stratification group, renal failure and others) were
examined with a chi-square (c2) test and ManneWhitney
U-test; odds ratios were calculated with the 95% confidence
levels. Probability values were compared with the p> 0.05
level used to determine statistical significance.
Results
Seventy-eight limbs in 76 patients were treated with this
combined simultaneous procedure over a 15-year period
(January 1992 to April 2007) for critical limb ischaemia (CLI)
Rutherford 6 (84%), major vascular trauma (13%) or large
tissue loss from gangrene resulting from multiple organ
failure with pre-existing arterial disease (3%).The majority of the patients were men: 62 men for 16
women, median age was 65.5 years (range: 18e80 years).
The most frequent location for free flap transfer was the
forefoot after open or non-healing forefoot amputation
(Table 1).
Risk factors are shown in Table 2 : 55 patients (70%) had
diabetes, 29 patients suffered from chronic renal insuffi-
ciency of whom three patients were on dialysis and three
previously had a kidney transplantation. Four patients had
a contralateral major amputation. 38% a documented
osteomyelitis on radiography and magnetic resonance
imaging (MRI) and one-third of the patients had undergone
a distal arterial reconstruction in the past.
The majority of the vascular procedures were popliteo-
pedal bypasses (Table 3), eight patients needed an arterial
reconstructions at two different levels.
A variety of muscular and non-muscular free flaps were
used to cover the defect (Table 4).Early results
The overall median operating time for a single-stage
procedure including anaesthesia time was 415 min (7 h)
(range: 150e730 min). Twenty-three patients (29%)
required an early re-intervention: six vascular bypasses
thrombosed, 13 free muscle flaps failed, two patients
needed a re-exploration for bleeding and one patient
developed a false aneurysm on the bypass which was
excised. One patient developed a forefoot necrosis after
connecting the flap to the posterior tibial artery (the only
outflow artery with a non-existing pedal arch) for heel
coverage due to a steal phenomenon from the flap and had
to be amputated. Four failing vascular bypasses were
treated by thrombectomy, combined with local thrombol-
ysis of the free flap; in the other two patients, a more distal
bypass was performed. Four failed free flaps required
a major amputation whereas the remaining patients were
re-explored. In five patients, the thrombi could be cleared
and a new arterial and venous anastomosis of the flap was
performed. Two patients were treated with a new free flap
transfer and two patients had granulation stimulation with
a vacuum device followed by a rotation flap and a skin graft
(STG). In five patients, a new STG had to be performed. The
overall early complication rate was 50% (Table 5).
Major medical complications occurred in six patients:
three developed congestive heart failure with fatal conse-
quence resulting in an in-hospital mortality rate of 3.8% and
three patients suffered a stroke that resolved without
persisting disability. Minor surgical complications were
numerous and included superficial wound dehiscence,
Table 2 Risk factors
Risk factor n %
 1 runoff vessel 74 95
Diabetes 55 70.5
Hypertension 41 53
Myocardial infarction
or cardiac insufficiency
38 49
Smoking 37 47
Renal insufficiency
or transplantation
32 41
Previous ipsilateral
vascular surgery
30 38
Osteomyelitis 30 38
Previous TIA/CVA 16 21
Dyslipidemia 10 12.8
Pulmonary disease 5 6
Coronary bypass
or PTCA
5 6
Contralateral amputation 4 5
Dialysis 3 4
Buerger’s disease 3 4
Table 4 Free muscle flaps used for reconstruction
Flaps n %
M rectus abdominis 59 76
M latissimus dorsi 9 12
Anterolateral thigh flap 3 4
Perforator flap 2 3
M serratus anterior 2 3
Combined M lat dorsiþM
rectus abdominis
1 1
Lateral arm flap 2 3
342 C. Randon et al.partial loss of skin graft and decubitus despite vigorous
prevention.
All operative lesions healed. Minor recurrence of ulcers
was encountered in two patients and healed with adapta-
tion of off-loading shoes.
Late results
Long-term follow-up was available in 70 limbs (three
patients died and five were amputated in the perioperative
period) for an average of 32.5 m (range: 1e180 m). During
follow-up, another 17 patients (21%) needed a major
amputation owing to progression of gangrene, vascular
graft occlusion or progression of atherosclerosis in the
outflow vessels. Twelve of these 17 patients (71%) had renal
insufficiency and the limbs of two of the three patients on
dialysis were amputated during follow-up. Five patientsTable 3 Type of vascular bypass
Type of bypass n %
Pedal 39
Femoro-pedal 13 17
Popliteo-pedal 21 27
Tibio-pedal 5 6
Tibial 29
Tibio-pedal 5 6
Femoro-tibial 16 21
Popliteo-tibial 8 10
Popliteal 10
Femoro-popliteal 3 10 13
Other 5
Femoral PTA 2 3
Profundoplasty 1 1required a new bypass; in five other patients the bypass
occluded without consequences for the free muscle flap.
Five angioplasties were performed for in-graft stenoses.
Fourteen patients died during follow-up. The limb salvage
ratio at 1, 3 and 5 years was 93%, 80% and 71%, respectively,
and the combined patient survival and limb-salvage rate
was 85%, 66% and 51% at 1, 3 and 5 years, respectively
(Fig. 4).
Sixty-five percent of the patients were still alive and
able to ambulate independently with the use of their
reconstructed limb 1 year after hospital discharge.
In the evaluation of possible predictive risk factors for
poor outcome, only previous foot operations/minor ampu-
tations were a statistically significant negative predictive
risk factor (p< 0.024, odds ratio: 9.049 (range: 1.336e
61.294)) for patient survival. For limb salvage, only renal
insufficiency (p< 0.002; odds ratio: 16.3 (range: 2.8e95.9))
and previous contralateral major amputation (p< 0.03;
odds ratio: 89.5 (range: 4.7e1701.7)) were very strong
predictors for limb loss. Diabetes alone, or in combination
with other risk factors, was not a statistically significant
risk factor for patient survival or limb loss. The type of flap,
the type of arterial re-vascularisation and the outflow state
(nearly all had only one outflow vessel) had no effect on
limb salvage.
Discussion
Combined re-vascularisation and free muscle flap transfer
was first described more than 20 years ago by Briggs3 et al.
The technique has been adapted all over the world butTable 5 Complications within 30 days
Early complications n %
Mortality
(congestive heart failure)
3 3.8
Flap loss 2 2.6
Major amputation 5 6.4
Pulmonary oedema 6 7.7
Infection (MRSA) 4 5.1
Hematoma 2 2.6
Bypass graft occlusion 6 7.7
Re-STG 7 9.0
Stroke 3 3.8
False aneurysm 1 1.3
6m 12m 24m 36m 60m 96m 180 
m
N at
risk
51 51 51 29 17 11 2 
SE 0.0347 0.0347 0.0347 0.0666 0.0858 0.0858 0.254 
6m 12m 24m 36m 60m 96m 180
m 
N at
risk
51 51 38 29 17 11 2 
SE 0.0443 0.0443 0.0484 0.0732 0.0777 0.0898 0.171
Combined patient survival and
limb salvage
Time (months)
0 20 40 60 80 100 120 140 160 180 200
0,0
0,2
0,4
0,6
0,8
1,0
Limb salvage
time (months)
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Figure 4 KaplaneMeier survival curve for limb salvage and patient survival.
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Cronenwett4 and Karp5 refined and validated this approach
for patients with large soft-tissue defects, especially on
weight-bearing surfaces of the foot and drew attention to
the increased outflow for the bypass brought by the muscle
flap. Mimoun et al.6 first made the observation that neo-
vascularisation of the surrounding ischemic tissue by
collaterals originating from the flap occurs as soon as
3 weeks after implantation and called this flap the ‘nic-
trient flap’. We confirmed this observation in a later
report.7 At a further stage, these collaterals can allow the
flap to survive, even when the bypass occludes. Shestak8
confirmed the fact that a free flap can serve as a sole
outflow for a bypass graft in patients with unacceptable or
no runoff.
The work of Lorenzetti9 showed that the transferred
muscle provides a low-resistance outflow bed, increasing
graft flow by up to 50% and that a steal phenomenon was
not to be feared even if a substantial part of the flow
through the bypass went to the muscle. Yet, we had one
patient who needed a major amputation despite an open
bypass due to a steal phenomenon of the flap on the heel
and progressive gangrene of the forefoot.
The misconception that patients with distal arterial
occlusions and major tissue loss (Rutherford 5e6), espe-
cially diabetes patients, are not suitable for reconstruction
has long been a motive for primary amputation: Chung10
observed that at 1-year follow-up up to 25% of his patients
with CLI did not realise wound healing despite a successful
re-vascularisation, 19% lost ambulatory function and 5% had
lost independent living status. Risk factors for amputation
despite a patent bypass graft were persistent ischaemia or
infection of the foot wound, poor wound healing, distal
outflow problems and the lack of durable wound coverage.
Adequate tissue coverage of the distal anastomotic site inpatients with large soft-tissue deficit is difficult and can
result in graft exposure and disruption of the graft or the
anastomosis. By covering the distal anastomosis site with
a free muscle flap, we can prevent disruption of the arterial
bypass and cover at the same time major soft-tissue
lesions. Our combined survival and limb-salvage rate was
85% after 1 year. As limb salvage has a clear impact on
quality of life and probably survival, we think that primary
amputation is only indicated in patients who are bedridden,
who have severe neurological impairment, and who have
a poor survival or poor predicted functional outcome after
re-vascularisation and free flap transfer.
The known risk factors for failures in patients with tissue
loss who undergo infra-inguinal vein bypass surgery are
diabetes, end-stage renal disease and poor run off.11 In our
study, only renal insufficiency and previous major ampu-
tation of the other limb were strong predictors for limb
loss. Therefore, this operation in patients with end-stage
renal disease or on dialysis was discontinued. The fact that
diabetes was no risk factor may be due to the fact that the
muscle flap increased the outflow. Tukiainen12e14
mentioned other predictive factors that enhance poor graft
outcome, such as male gender and the size of the ulcer
(>10 cm2). All our patients had an ulcer larger than 10 cm2.
Another misconception about this combined procedure
is the high mortality rate. We agree that we had a lot of
minor complications (50%) and a high number of early re-
interventions, although these resulted in only five major
amputations. However, our in-hospital mortality rate of
3.8% compares favourably to the mortality rates after
major amputation that can be as high as 50%.
Even our 1-year mortality and amputation rate of 15%
and 7% are consistent with the 1-year mortality (10%) and
amputation rate (5e10%) in patients with CLI and just minor
tissue deficit. Postoperative mortality was only attributable
Table 6 Combined procedures in literature (>10 patients)
Author Year n (Flaps) Diabetes (%) Graft and
flap survival
Patient survival Limb salvage
Cronenwett4 1989 14 86% 2 y: 93% 1 pt died 2 y: 93%
Oishi15 1993 19 100% nm 22 m: 89.5% 22 m:72%
Karp5 1994 19 100% 1 pt died 5 pts
Gooden16 1997 17 nm nm nm 2 y: 70%
Mc Carthy17 1999 21 86% 13 m: 71% 13 m: 90% 13 m: 86%
Quinones-Baldrich18 2002 15 80% nm nm 3 y: 72%
Serletti/Illig/Moran19e21 2002 61 76% 5 y: 60% 5 y: 67% 5 y: 63%
Czerny22 2004 25 68% 51 m: 77% 4 y: 80% 51 m: 84%
Verhelle23 2004 19 100% 1 y:84% 16 m 94.4%
Tukiainen/Lepantalo12e
14,24
2006 81 25% 5 y: 66% 5 y: 63%/ASA4:45% 5 y: 41%/ASA 4: 30%
Our results7,25,26 2008 78 70.5% 5 y: 70% 5 y: 51% 5 y: 70%
NMZ not mentioned.
344 C. Randon et al.to cardiac causes. This stresses the importance of a thor-
ough cardiac evaluation and adequate management before,
during and after the intervention. Our low mortality rate
could only be achieved due to a meticulous cardiac work-
up. Under these conditions, the expanded operation and
extended operation time do not seem to adversely affect
the perioperative mortality rate.
Despite the advanced stage of vascular disease in all our
patients, our 5-year limb-salvage rate of 71% is comparable
to the limb-salvage rate obtained after arterial re-vascu-
larisation for critical limb ischaemia alone.1 Only a few
centres published the results about combined re-vascular-
isation and free-tissue transfer (with exclusion of omental
flaps) in more than 10 patients (Table 6). In these series and
related to the disease itself, late mortality is often high and
follow-up limited. Nevertheless, a 3-year limb-salvage rate
about 70% could be obtained in most series. We obtained
a similar limb-salvage rate even after 5 years.
During the last years, growing interest has arisen for new
wound-healing techniques, such as vacuum-assisted closure
or negative pressure treatment. This has been proposed as
an alternative for this technique as it would enhance wound
healing and allow the formation of granulating tissue over
bones and tendons. However, in patients with arterial
compromise, this technique will only work after a re-vas-
cularisation has been performed. Time to healing with
these conservative techniques is much longer, and it cannot
be used on weight-bearing surfaces and cannot be
combined with a pedal bypass to the affected region.
Although this is a valuable technique, it is an alternative for
the combined technique in only a limited number of
patients.
Conclusion
Our results show that arterial re-vascularisation in combi-
nation with free-tissue transfer can be performed safely
with acceptable morbidity and mortality. In patients with
large soft-tissue defects that cannot be expected to heal in
a reasonable time it should be preferred over a major
amputation. Only end-stage renal disease should beconsidered as a contraindication. The combination of both
procedures in one intervention has several advantages:
a supplementary outflow is created for the vascular
reconstruction, the arterial and venous anastomoses with
the free flap are easier to perform and an immediate
coverage of the defect is obtained. The vast majority of our
patients were able to regain ambulatory function.
Our 5-year results can be considered as excellent and
illustrate the improvement of limb salvage and, therefore,
of quality of life, that can be obtained in these patients.Acknowledgements
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